Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens.
Trans-differentiation of stem cells shows promise for use in tissue repair medicine. Although poorly defined, mesenchymal stem cells (MSC) appear useful for applications in repair medicine. Despite the low frequency of MSC, they are relatively easy to expand. The expression of MHC class II on MSC, however, could deter their use in repair medicine, since these molecules could stimulate an allogeneic host response. This study sought to compare the immune stimulatory and suppressive effects of MSC. Primary human MSC were cultured from bone marrow aspirates and then passaged at least three times before use in assays. Morphologically, MSC were symmetrical; were SH2(+), MHC class II(+), CD45(-), CD44(+), CD31(-), CD14(-), proly-4-hydroxylase(-); and showed normal karyotype patterns and elevated telomerase activities. MSC elicited significant stimulatory responses when cocultured with allogeneic PBMC. Despite the production of different types of growth factors, allogeneic effects of MSC could not be explained by the production of these growth factors. One-way MLR reactions were significantly blunted by third-party MSC. Similar suppression was not observed for responses to three different recall Ags. Based on these functional differences by MSC in responses to allo- and recall Ags, we examined whether MSC could exert veto-like functions. We showed that MSC could blunt the cytotoxic effects of allogeneic-induced effectors to mitogen-activated targets. The results showed that although MSC elicited allogeneic responses in a model that mimics a graft-vs-host reaction, they also exerted veto-like activity, but caused no effect on responses to recall Ags.
D000328:Adult; D015703:Antigens, CD / Q000276:immunology; D001707:Biopsy, Needle; D001854:Bone Marrow Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000528:radiation effects; D002474:Cell-Free System / Q000276:immunology / Q000378:metabolism; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D003601:Cytotoxicity Tests, Immunologic; D000071063:Endoglin; D005347:Fibroblasts / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000528:radiation effects; D005557:Formaldehyde / Q000494:pharmacology; D005720:Gamma Rays; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000528:radiation effects; D007156:Immunologic Memory / Q000187:drug effects / Q000528:radiation effects; D007519:Isoantigens / Q000502:physiology*; D007959:Lymphocyte Culture Test, Mixed / Q000379:methods; D008648:Mesoderm / Q000166:cytology / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000276:immunology; D020411:Oligonucleotide Array Sequence Analysis; D011108:Polymers / Q000494:pharmacology; D011393:Procollagen-Proline Dioxygenase / Q000502:physiology; D011956:Receptors, Cell Surface; D013234:Stem Cells / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism / Q000528:radiation effects; D019010:Vascular Cell Adhesion Molecule-1 / Q000276:immunology
D015703:Antigens, CD; D016207:Cytokines; C064206:ENG protein, human; D000071063:Endoglin; D000949:Histocompatibility Antigens Class II; D007519:Isoantigens; D009419:Nerve Tissue Proteins; D011108:Polymers; D011956:Receptors, Cell Surface; D019010:Vascular Cell Adhesion Molecule-1; D005557:Formaldehyde; D011393:Procollagen-Proline Dioxygenase; C003043:paraform